Nano-X Imaging Ltd.

NNOX Healthcare Medical Devices

Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.7%, EPS fell 243.5%, free cash flow fell 21.4% and total debt fell 12.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

0.45 0.04 −8.16%
Market cap
$38.6M
P/E
0.0×
Fwd P/E
−2.9×
Dividend yield
—
F-score
3/9
Altman Z
−0.16
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
3 4 3 3

+8 more TTM periods

ROE
(98.98%) (50.12%) (45.62%) (34.75%)
ROA
(84.82%) (44.40%) (40.31%) (30.95%)
ROIC
(168.62%) (57.58%) (52.17%) (31.48%)
Return on Tangible Assets
(205.34%) (112.22%) (94.27%) (65.02%)
Average Days of Receivables
44.06 55.54 56.43 57.47
Free Cash Flow per Share
(0.74) (0.72) (0.69) (0.70)
Free Cash Flow
(52.09) (49.88) (45.00) (45.27)
Capital Expenditures
(5.39) (5.46) (4.21) (4.36)
Other line items
Cash ROIC
(48.95%) (28.81%) (23.44%) (22.07%)
Accounts Receivable Turnover
8.30 7.39 6.82 7.18
Accounts Payable Turnover
30.92 12.38 10.13 17.76
Inventory Turnover
24.13 10.69 11.31 13.17
Average Days of Payables
11.41 32.55 40.81 21.15
Days of Inventory on Hand
18.24 44.52 43.42 39.97
Tax Rate
(0.01) (0.02) (0.02) 0.00
Research and Development Expense of Revenue
121.08% 131.27% 147.73% 160.94%
Selling, General and Administrative Expense of Revenue
189.07% 196.87% 209.29% 210.39%
Share Based Compensation of Revenue
23.18% 26.62% 32.18% 38.95%
Operating CF/Net income
0.40 0.58 0.54 0.73
Depreciation/Fixed assets
0.36 0.38 0.40 0.25
Capex/Depreciation
(0.47) (0.47) (0.36) (0.37)
Revenue per Share
0.22 0.21 0.20 0.19
Operating CF per Share
(0.67) (0.64) (0.63) (0.64)
Capex per Share
(0.08) (0.08) (0.06) (0.07)
Capex to Sales
0.34 0.38 0.32 0.35

Fold the line items

Columns are period end dates